ARPA-H selected innovation teams in June 2026 for the ADVOCATE program, a three-year federally funded effort to build the first FDA-authorized autonomous AI agent capable of providing around-the-clock ...
In this single-group, open-label trial, olorofim was associated with a complete or partial clinical response in over 75% of patients with disseminated coccidioidomycosis (DCM) and limited or no ...
Advanced Medical Care at Home Among Patients With Acute Heart Failure 1. Following hospitalization for acute decompensated heart failure (HF), there was no difference in all-cause readmissions and ...
Erector spinae plane blocks reduced PACU opioid requirements and modestly shortened PACU stay, but did not produce a clinically meaningful reduction in total opioid consumption over 24 hours. 2. Pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results